Stocks · Health care · Pharmaceutical Preparations

ACADIA PHARMACEUTICALS INC

ACAD Clue Score69

United States Fiscal year ends December CIK 0001070494 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Mark C. Schneyer

6 Aug 2026

EVP, Chief Financial Officer

Sold after exercise

9,292

$29.34

$272.60K

Mark C. Schneyer

6 Aug 2026

EVP, Chief Financial Officer

Sold after exercise

5,000

$29.00

$145.00K

Mark C. Schneyer

5 Aug 2026

EVP, Chief Financial Officer

Sold after exercise

5,849

$29.00

$169.64K

Mark C. Schneyer

25 Mar 2026

EVP, Chief Financial Officer

Sold after exercise

4,177

$21.47

$89.68K

James Kihara

25 Mar 2026

Principal Accounting Officer

Sold after exercise

833

$21.47

$17.88K

Show all 25 transactions →

What was left out

Form 4 filings counted 32

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 5

Sales at will 19

Transactions with no price 0

Shares from compensation/vesting 252,240

History held since 13 Dec 2006